AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2021
Apr 5, 2021
34152_dirs_2021-04-05_cbeb7c06-0f06-47aa-b85d-4da1e6aa60ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Armata Pharmaceuticals, Inc. (ARMP)
CIK: 0000921114
Period of Report: 2021-04-01
Reporting Person: Haimovitz Jules (Director)
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Regulatory Filings
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23